Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16
- 1 October 2020
- journal article
- letter
- Published by Elsevier in European Urology Oncology
- Vol. 3 (5) , 713
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy featuresUrologic Oncology: Seminars and Original Investigations, 2020
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre studyThe Lancet, 2020
- Number of Unfavorable Intermediate‐Risk Factors Predicts Pathologic Upstaging and Prostate Cancer‐Specific Mortality Following Radical Prostatectomy: Results From the SEARCH DatabaseThe Prostate, 2016